Document ID: chunk:federal_register_of_legislation:F2025L00215:schedule:1:p11
Version: federal_register_of_legislation:F2025L00215
Segment Type: schedule
Provision Reference: sch 1 (pt 11/51)
Character Range: 29700–32870

P16306 P16349  60  6     60

[60] Schedule 1, Part 1, entries for Ozanimod
substitute:
Ozanimod  Capsule 920 micrograms                                                   Oral  Zeposia  BQ  MP     C13995 C14003 C14004 C14005  P13995 P14003 P14004 P14005  28  3     28
Ozanimod  Capsule 920 micrograms                                                   Oral  Zeposia  BQ  MP NP  C16301 C16323                P16301 P16323                28  5     28
Ozanimod  Capsule 920 micrograms                                                   Oral  Zeposia  BQ  MP     C13946 C14002                P13946 P14002                28  5     28
Ozanimod  Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms  Oral  Zeposia  BQ  MP NP  C16301 C16323                                             1   0     1
Ozanimod  Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms  Oral  Zeposia  BQ  MP     C14017                                                    1   0     1

[61] Schedule 1, Part 1, entry for Peginterferon beta-1a in the form Pack containing single use injection pens containing 63 micrograms in 0.5 mL and 94 micrograms in 0.5 mL
(a) omit from the column headed "Authorised Prescriber": MP substitute: MP NP
(b) omit from the column headed "Circumstances": C7695 substitute: C16321
[62] Schedule 1, Part 1, entry for Peginterferon beta-1a in the form Single use injection pen containing 125 micrograms in 0.5 mL [Maximum Quantity: 2; Number of Repeats: 4]
(a) omit from the column headed "Authorised Prescriber": MP substitute: MP NP
(b) omit from the column headed "Circumstances": C7695 substitute: C16321
(c) omit from the column headed "Purposes": P7695 substitute: P16321
[63] Schedule 1, Part 1, entry for Peginterferon beta-1a in the form Single use injection pen containing 125 micrograms in 0.5 mL [Maximum Quantity: 2; Number of Repeats: 5]
(a) omit from the column headed "Authorised Prescriber": MP substitute: MP NP
(b) omit from the column headed "Circumstances": C6860 substitute: C16297
(c) omit from the column headed "Purposes": P6860 substitute: P16297
[64] Schedule 1, Part 1, entry for Permethrin in the form Cream 50 mg per g, 30 g
omit from the column headed "Responsible Person": ON substitute: UI
[65] Schedule 1, Part 1, entries for Pirfenidone in the form Tablet 801mg
omit from the column headed "Form" (all instances): Tablet 801mg substitute (all instances): Tablet 801 mg
[66] Schedule 1, Part 1, entries for Pregabalin in the form Capsule 150 mg
omit:
Pregabalin  Capsule 150 mg  Oral  Cipla Pregabalin  LR  MP NP  C4172     56  5     56

[67] Schedule 1, Part 1, after entry for Prochlorperazine in the form Tablet containing prochlorperazine maleate 5 mg [Brand: Stemetil]
insert:
Progesterone  Capsule 100 mg  Oral  Prometrium  HB  MP NP             30  5     30
Progesterone  Capsule 100 mg  Oral  Prometrium  HB  MP NP     P14238  60  5     30

[68] Schedule 1, Part 1, after entry for Progesterone in the form Vaginal tablet 100 mg
insert:
Progesterone and estradiol  Pack containing 30 capsules progesterone 100 mg (micronised) and transdermal gel (pump pack) estradiol 750 micrograms (as hemihydrate)